Globalinsulin delivery system market

1
Global Insulin Delivery System Market to Reach to
USD 13.84 Billion by 2023 Infinium Global
Research
2
The report on Insulin Delivery System by Infinium
Global Research analyses the Insulin Delivery
System Market over the period of 2017 to 2023.
Moreover, the IGR-Growth Matrix given in the
report provides key focus areas and investment
areas the market players can focus on. The
market size is presented in terms of value for
the historic year 2015 and estimated for
forecast period of 2017 to 2023. Get Sample Copy
of this Report https//www.infiniumglobalresearc
h.com/Reports/MakeSampleRequest/806 According
to the report, the global insulin delivery system
market is anticipated to reach to USD 13.84
billion in 2023. The report identified that the
global market for insulin delivery systems was
dominated by the Americas region followed by the
Europeaninsulin delivery system market in 2015
and 2016. On the basis of countries, the U.S. led
the global insulin delivery system market due to
improvement in healthcare scheme such as offering
compensation. Patient are
3
moving from hospitals to speciality clinics, User
prefer syringes and insulin pens because of
their low cost, refining policies for
compensation, and availability, affordability of
devices, are some of the key factor driving the
growth of global insulin delivery system market
Moreover, needle nervousness in patients affect
the growth of the pen needles and syringes
market, and, problems related with the reuse of
pen needles and infusion sets are the key factors
restraining the growth of this market. Get 15
discount for early purchase of global Insulin
delivery system market by region (North America,
Europe, Asia Pacific, Latin America and RoW)
report on https//www.infiniumglobalresearch.com/R
eports/requestdiscount/806 Growing research and
development, increasing expenditure in emerging
economies on diabetes-related health are likely
to bring more opportunities to this market.
4
The report segments the global insulin delivery
system market in terms of product types and
applications. Among the product type the insulin
pen accounted for the largest share over the
period of 2015 and 2016. The companies covered
in the report include ELI Lilly and Company,
Ypsomed Holding AG, Becton, Dickinson and
Company, Novo Nordisk A/S, Tandem Diabetes Care,
Inc., Medtronic PLC, Sanofi, Animas Corporation
(Johnson and Johnson), Insulet Corporation,
Biocon Limited. Make an Enquiry _at_
https//www.infiniumglobalresearch.com/Reports/Mak
eEnquiryRequest/806
About Infinium Global Research Infinium Global
Research is a business intelligence company that
provides its clients with market information
services, solutions, and reports. The
intelligence reports include qualitative
5
as well as quantitative information, which are
blended using forecasting models in order to
project future market demand. Our panels of
Subject Matter Experts (SMEs), Analysts, and
Consultants use numerous data gathering tools in
order to provide you with detailed information
on the market as well as a preview of its
projected growth. Our repository includes the
largest and most credible databases, through
which we determine various qualitative and
quantitative parameters of the market to provide
you with an in-depth business intelligence report.